Literature DB >> 23344626

Is there a difference in gastric emptying between myotonic dystrophy type 1 patients with and without gastrointestinal symptoms?

Yuji Tanaka1, Tomohiro Kato, Hiroshi Nishida, Megumi Yamada, Akihiro Koumura, Takeo Sakurai, Yuichi Hayashi, Akio Kimura, Isao Hozumi, Hiroshi Araki, Masahiko Murase, Masahito Nagaki, Hisataka Moriwaki, Takashi Inuzuka.   

Abstract

Gastrointestinal symptoms are frequent complaints in patients with myotonic dystrophy type 1 (MyD1) and may be associated with reduced gastrointestinal motility caused by smooth muscle dysfunction. Although previous studies have found delayed gastric emptying (GE) in MyD1 patients, the relationship between GE and symptoms has been unclear. We investigated GE in 23 MyD1 patients and 20 healthy volunteers using the 13C-acetate breath test. The MyD1 patients were divided into two groups: those with gastrointestinal symptoms (n = 9) and those without gastrointestinal symptoms (n = 14). The GE function was estimated using the 13C-acetate breath test as half-emptying time (HET) and peak time of the 13C-%-dose-excess curve (T max). GE (HET and T max) was more significantly delayed in patients with MyD1 than in the controls. The GE in MyD1 patients with gastrointestinal symptoms was significantly delayed compared to those without gastrointestinal symptoms. The GE in MyD1 patients with gastrointestinal symptoms was more significantly delayed than in the controls. The GE was significantly delayed in MyD1 patients with gastrointestinal symptoms for >5 years as compared to those with the disease for <5 years, while GE of MyD1 patients without gastrointestinal symptoms did not correlate with the duration of the disease. The GE in MyD1 patients did not correlate with the muscular disability rating scale. These findings suggest that impairment of GE evolves over time and that the progression of delayed GE and skeletal muscle impairment are independent. Smooth muscle impairment may be affected at an earlier stage in MyD1.

Entities:  

Mesh:

Year:  2013        PMID: 23344626     DOI: 10.1007/s00415-013-6842-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy.

Authors:  A Rönnblom; P M Hellström; J J Holst; E Theodorsson; A Danielsson
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 2.566

Review 2.  [The gastrointestinal changes in dystrophia myotonica].

Authors:  L Bujanda; A López de Munain; A Alcón; M A Gutiérrez Stampa; A Martínez Pérez-Balsa; J I Arenas
Journal:  Rev Esp Enferm Dig       Date:  1997-09       Impact factor: 2.086

Review 3.  Gastrointestinal manifestations in myotonic muscular dystrophy.

Authors:  Massimo Bellini; Sonia Biagi; Cristina Stasi; Francesco Costa; Maria Gloria Mumolo; Angelo Ricchiuti; Santino Marchi
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

4.  Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test.

Authors:  Yuji Tanaka; Tomohiro Kato; Hiroshi Nishida; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Yuichi Hayashi; Akio Kimura; Isao Hozumi; Hiroshi Araki; Masahiko Murase; Masahito Nagaki; Hisataka Moriwaki; Takashi Inuzuka
Journal:  J Neurol       Date:  2010-10-12       Impact factor: 4.849

5.  Gastrointestinal symptoms in myotonic dystrophy.

Authors:  A Rönnblom; H Forsberg; A Danielsson
Journal:  Scand J Gastroenterol       Date:  1996-07       Impact factor: 2.423

6.  The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals.

Authors:  B Braden; S Adams; L P Duan; K H Orth; F D Maul; B Lembcke; G Hör; W F Caspary
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

7.  Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test.

Authors:  Yuji Tanaka; Tomohiro Kato; Hiroshi Nishida; Hiroshi Araki; Masahiko Murase; Masahito Nagaki; Hisataka Moriwaki; Takashi Inuzuka
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

8.  Somatic instability of CTG repeat in myotonic dystrophy.

Authors:  T Ashizawa; J R Dubel; Y Harati
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

9.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

10.  Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test.

Authors:  Y F Ghoos; B D Maes; B J Geypens; G Mys; M I Hiele; P J Rutgeerts; G Vantrappen
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  4 in total

1.  Urge incontinence and gastrointestinal symptoms in adult patients with pompe disease: a cross-sectional survey.

Authors:  Nesrin Karabul; Anika Skudlarek; Janine Berndt; Cornelia Kornblum; Rudolf A Kley; Stephan Wenninger; Nikolaus Tiling; Eugen Mengel; Ursula Plöckinger; Matthias Vorgerd; Marcus Deschauer; Benedikt Schoser; Frank Hanisch
Journal:  JIMD Rep       Date:  2014-08-26

Review 2.  A Case Report of Myotonic Disease and Gastric Bypass and a Literature Review.

Authors:  H Gohier; P Cintas; E Montastier; M Bertrand; G Tuyeras; M Chalret du Rieu; A Estrade; P Ritz
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

3.  Myotonic Dystrophy Type 1 Complicated by Colonic Obstruction Due to a Bezoar.

Authors:  Aaron de Souza; Sanjeev Gupta
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

4.  High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.

Authors:  James E Hilbert; Richard J Barohn; Paula R Clemens; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Amy L Parkhill; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  Neurology       Date:  2017-08-30       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.